Dr Brenda Joy Schmidt, MD | |
2111 Exchange St, Astoria, OR 97103-3329 | |
(503) 325-4321 | |
Not Available |
Full Name | Dr Brenda Joy Schmidt |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2111 Exchange St, Astoria, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881758951 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD60846825 (Washington) | Secondary |
208600000X | Surgery | MED-PHYS-LIC-67074 (Montana) | Secondary |
208600000X | Surgery | MD187052 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Brenda Joy Schmidt, MD 3245 University Ave # 259, San Diego, CA 92104-2009 Ph: () - | Dr Brenda Joy Schmidt, MD 2111 Exchange St, Astoria, OR 97103-3329 Ph: (503) 325-4321 |
News Archive
With BackCare Awareness Week reiterating the fact that 80 per cent of people, who work across all industries and professions, will suffer from back pain at some point in their lives, workplace equipment supplier Slingsby says that nearly all work related back pain can be avoided.
A UCLA research team has found a combination of proteins that could significantly improve clinical bone restoration. The findings may be a big step toward developing effective therapeutic treatments for bone skeletal defects, bone loss and osteoporosis.
Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago
Dr. Ali Dowlatdad, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2055 Exchange St, Suite 270, Astoria, OR 97103 Phone: 503-325-9597 Fax: 503-325-9639 | |
Truman M Sasaki, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2055 Exchange St, Suite 290, Astoria, OR 97103 Phone: 503-338-5353 Fax: 503-338-5252 | |
Juliette Moore, MD Surgery Medicare: Medicare Enrolled Practice Location: 2055 Exchange St Ste 270, Astoria, OR 97103 Phone: 503-338-4670 Fax: 503-338-4671 | |
Dr. Eric Zimmermann, MD Surgery Medicare: Medicare Enrolled Practice Location: 2055 Exchange St Ste 270, Astoria, OR 97103 Phone: 503-338-4670 Fax: 503-338-4671 | |
Dr. Richard Arthur Crass, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-325-4321 Fax: 503-338-4018 |